Uterine Pathology II Flashcards
type 1 endometrium epithelium adenocarcinoma
glandular - endometroid
type 2 endometrium epithelium adenocarcinoma
surface - non-endometroid
-papillary serous carcinoma
MMMT - carcinomcarcinoma
myometrium neoplasms
leiomyoma
leiomyosarcoma
endometroid adenocarcinoma
type 1
80% of endometrial cancer
peak age 45-55yo
with conditions of unopposed estrogen
mutations of endometroid adenocarcinoma
type 1
PTEN - mutation
KRAS - microsatellite instability
conditions of unopposed estrogen
exogenous estrogen 10 years endogenous - ovarian tumor estrogen from peripheral conversion of androgen - PCOS, obesity, androgen tumor infertility diabetes HTN
abnormal bleeding, prolonged periods of 6 month duration
endometroid adenocarcinoma - type 1
grade of endometroid adenocarcinoma
based on number of lumens
tamoxifen
risk fx for type 1 - endometroid adenocarcinoma of uterus
absence of PTEN stain
type 1 - endometroid adenocarcinoma
non-endometroid adenocarcinoma
type 2
- all high grade and aggressive**
- early lymph spread
papillary serous carcinoma
15% of endometrial carcinomas
post-menopausal disease**
cancer of endometrium post-menopause
type 2
mutation in p53
non-endometroid adenocarcinoma of endometrium - type 2
MMMT
malignant mixed mullerian tumor
carcinosarcoma
bulky polypoid mass
distinct epithelial and mesenchymal components**
papillary architecture
serous carcinoma - type 2 non-endometroid adenocarcinoma
positive p53
non-endometroid adenocarcinoma
precursor to type 1
hyperplasia / EIN
precursor to type 2
endometrial intraepithelial carcinoma
african america, thin, atrophy
type 2 endometrial cancer
grade and stage of endometrium cancer
grade - differentiation
1 - well
2 - moderate
3 - poor
stage - location 1 - corpus uteri 2 - corpus and cervix 3 - extends outside uterus 4 - outside true pelvis or mucosa of bladder/rectum